|
Market Closed -
NYSE
16:00:03 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 244.51 USD | +0.26% |
|
+3.50% | +40.90% |
Company Valuation: Quest Diagnostics Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,224 | 17,817 | 15,503 | 16,838 | 19,304 | 26,987 | - | - |
| Change | - | -16.05% | -12.99% | 8.62% | 14.64% | 39.8% | - | - |
| Enterprise Value (EV) 1 | 24,364 | 21,482 | 19,683 | 22,679 | 24,555 | 32,034 | 31,368 | 30,816 |
| Change | - | -11.83% | -8.37% | 15.23% | 8.27% | 30.46% | -2.08% | -1.76% |
| P/E | 11.1x | 19.6x | 18.4x | 19.6x | 19.8x | 24.1x | 22.2x | 20x |
| PBR | 3.19x | 2.95x | 2.43x | 2.47x | 2.73x | 3.36x | 3.07x | 2.87x |
| PEG | - | -0.4x | -3.06x | 7.34x | 1.4x | 1.5x | 2.58x | 1.9x |
| Capitalization / Revenue | 1.97x | 1.8x | 1.68x | 1.71x | 1.75x | 2.25x | 2.15x | 2.06x |
| EV / Revenue | 2.26x | 2.17x | 2.13x | 2.3x | 2.23x | 2.67x | 2.5x | 2.35x |
| EV / EBITDA | 8.49x | 10.4x | 11x | 11.2x | 11.3x | 13.5x | 11.7x | 10.7x |
| EV / EBIT | 9.9x | 12.3x | 13.5x | 14.7x | 14x | 16.7x | 15.4x | 14.1x |
| EV / FCF | 13.3x | 16.3x | 22.8x | 24.9x | 18.1x | 26.1x | 23.6x | 21.5x |
| FCF Yield | 7.51% | 6.12% | 4.39% | 4.01% | 5.53% | 3.83% | 4.24% | 4.66% |
| Dividend per Share 2 | 2.64 | 2.64 | 2.84 | 3 | 3.2 | 3.295 | 3.294 | 3.46 |
| Rate of return | 1.53% | 1.69% | 2.06% | 1.99% | 1.84% | 1.35% | 1.35% | 1.42% |
| EPS 2 | 15.55 | 7.97 | 7.49 | 7.69 | 8.75 | 10.16 | 11.03 | 12.22 |
| Distribution rate | 17% | 33.1% | 37.9% | 39% | 36.6% | 32.4% | 29.8% | 28.3% |
| Net sales 1 | 10,788 | 9,883 | 9,252 | 9,872 | 11,035 | 12,007 | 12,570 | 13,088 |
| EBITDA 1 | 2,870 | 2,059 | 1,788 | 2,034 | 2,175 | 2,369 | 2,681 | 2,878 |
| EBIT 1 | 2,462 | 1,742 | 1,457 | 1,541 | 1,759 | 1,914 | 2,041 | 2,187 |
| Net income 1 | 1,995 | 946 | 854 | 871 | 992 | 1,146 | 1,235 | 1,349 |
| Net Debt 1 | 3,140 | 3,665 | 4,180 | 5,841 | 5,251 | 5,047 | 4,381 | 3,829 |
| Reference price 2 | 173.01 | 156.44 | 137.88 | 150.86 | 173.53 | 244.51 | 244.51 | 244.51 |
| Nbr of stocks (in thousands) | 122,675 | 113,887 | 112,435 | 111,615 | 111,242 | 110,373 | - | - |
| Announcement Date | 2/3/22 | 2/2/23 | 2/1/24 | 1/30/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.06x | 2.67x | 13.52x | 1.35% | 26.99B | ||
| 13.68x | 0.41x | 8.59x | 2.86% | 119B | ||
| 14.49x | 1.82x | 9.08x | 0.72% | 92.83B | ||
| 13.99x | 1.52x | 9.18x | 2.55% | 30.13B | ||
| 8.25x | 1.46x | 6.65x | -.--% | 21.89B | ||
| 33.17x | 5.95x | 24.46x | 2.09% | 22.44B | ||
| 16.63x | 1.53x | 7.73x | 4.76% | 15.27B | ||
| 13.9x | 1x | 5.63x | 3.54% | 12.48B | ||
| 12.2x | 1.57x | 7.59x | 0.94% | 11.34B | ||
| 7.74x | 0.84x | 5.88x | 0.47% | 10.36B | ||
| Average | 15.81x | 1.88x | 9.83x | 1.93% | 36.25B | |
| Weighted average by Cap. | 15.48x | 1.55x | 9.75x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DGX Stock
- Valuation Quest Diagnostics Incorporated
Select your edition
All financial news and data tailored to specific country editions
















